EGI moves into neuromodulation
EGI's new Geodesic Transcranial Electrical Neuromodulation (GTEN) technology was demonstrated earlier this year at the Human Brain Mapping meeting in Honolulu. GTEN integrates EGI's core GES 400 dEEG platform and its proprietary head modeling algorithms to create a new technique for very precise neuromodulation. This product will be released first for use in research. Potential future medical applications for the new technology include epilepsy, depression, and tinnitus, among others.
Read the press release. Read more about GTEN technology.
EGI is a medical device company that designs, develops and commercialises a range of non-invasive neurodiagnostic products used to monitor and interpret brain activity. A key component of these products is EGI’s proprietary dense array electroencephalography (dEEG) platform technology. The dense array method gathers brain activity data from many more electrodes than conventional EEG products (up to 256), generating significantly higher quality and more precise levels of information. With regulatory clearance in the US, EU and a number of other major international regulatory bodies, the Company’s technology has been increasingly adopted as a powerful research tool and more recently as a cost effective and patient friendly clinical neurodiagnostic platform.